Revolution Medicines, Inc. (NASDAQ:RVMDW) Short Interest Down 91.5% in November

Revolution Medicines, Inc. (NASDAQ:RVMDW) was the target of a significant decrease in short interest during the month of November. As of November 15th, there was short interest totalling 400 shares, a decrease of 91.5% from the October 31st total of 4,700 shares. Based on an average daily trading volume, of 35,900 shares, the short-interest ratio is presently 0.0 days.

Revolution Medicines Stock Performance

Shares of RVMDW remained flat at $0.40 during mid-day trading on Thursday. 188 shares of the stock traded hands, compared to its average volume of 18,743. Revolution Medicines has a twelve month low of $0.03 and a twelve month high of $1.00. The company has a fifty day simple moving average of $0.27 and a 200 day simple moving average of $0.18.

About Revolution Medicines

Revolution Medicines, Inc, a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies.